252 related articles for article (PubMed ID: 29455657)
1. Role of the HGF/c-MET tyrosine kinase inhibitors in metastasic melanoma.
Demkova L; Kucerova L
Mol Cancer; 2018 Feb; 17(1):26. PubMed ID: 29455657
[TBL] [Abstract][Full Text] [Related]
2. Quercetin inhibits HGF/c-Met signaling and HGF-stimulated melanoma cell migration and invasion.
Cao HH; Cheng CY; Su T; Fu XQ; Guo H; Li T; Tse AK; Kwan HY; Yu H; Yu ZL
Mol Cancer; 2015 May; 14():103. PubMed ID: 25971889
[TBL] [Abstract][Full Text] [Related]
3. Hepatocyte growth factor/MET in cancer progression and biomarker discovery.
Matsumoto K; Umitsu M; De Silva DM; Roy A; Bottaro DP
Cancer Sci; 2017 Mar; 108(3):296-307. PubMed ID: 28064454
[TBL] [Abstract][Full Text] [Related]
4. Ezrin mediates both HGF/Met autocrine and non-autocrine signaling-induced metastasis in melanoma.
Huang L; Qin Y; Zuo Q; Bhatnagar K; Xiong J; Merlino G; Yu Y
Int J Cancer; 2018 Apr; 142(8):1652-1663. PubMed ID: 29210059
[TBL] [Abstract][Full Text] [Related]
5. Roles of the HGF/Met signaling in head and neck squamous cell carcinoma: Focus on tumor immunity (Review).
Liu D; Zhong M; Zhan D; Zhang Y; Liu S
Oncol Rep; 2020 Dec; 44(6):2337-2344. PubMed ID: 33125120
[TBL] [Abstract][Full Text] [Related]
6. The Interplay between HGF/c-met Axis and Nox4 in BRAF Mutated Melanoma.
Beretti F; Farnetani F; Reggiani Bonetti L; Fabbiani L; Zavatti M; Maiorana A; Pellacani G; Maraldi T
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33451139
[TBL] [Abstract][Full Text] [Related]
7. c-Met autocrine activation induces development of malignant melanoma and acquisition of the metastatic phenotype.
Otsuka T; Takayama H; Sharp R; Celli G; LaRochelle WJ; Bottaro DP; Ellmore N; Vieira W; Owens JW; Anver M; Merlino G
Cancer Res; 1998 Nov; 58(22):5157-67. PubMed ID: 9823327
[TBL] [Abstract][Full Text] [Related]
8. A mini-review of c-Met as a potential therapeutic target in melanoma.
Al-U'datt DGF; Al-Husein BAA; Qasaimeh GR
Biomed Pharmacother; 2017 Apr; 88():194-202. PubMed ID: 28107696
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic regulation of HGF/Met receptor axis is critical for the outgrowth of bone metastasis from breast carcinoma.
Bendinelli P; Maroni P; Matteucci E; Desiderio MA
Cell Death Dis; 2017 Feb; 8(2):e2578. PubMed ID: 28151481
[TBL] [Abstract][Full Text] [Related]
10. c-Met is a potentially new therapeutic target for treatment of human melanoma.
Puri N; Ahmed S; Janamanchi V; Tretiakova M; Zumba O; Krausz T; Jagadeeswaran R; Salgia R
Clin Cancer Res; 2007 Apr; 13(7):2246-53. PubMed ID: 17404109
[TBL] [Abstract][Full Text] [Related]
11. HGF/c-MET Signaling in Melanocytes and Melanoma.
Czyz M
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30513872
[TBL] [Abstract][Full Text] [Related]
12. BMS-777607, a small-molecule met kinase inhibitor, suppresses hepatocyte growth factor-stimulated prostate cancer metastatic phenotype in vitro.
Dai Y; Siemann DW
Mol Cancer Ther; 2010 Jun; 9(6):1554-61. PubMed ID: 20515943
[TBL] [Abstract][Full Text] [Related]
13. The HGF-MET axis coordinates liver cancer metabolism and autophagy for chemotherapeutic resistance.
Huang X; Gan G; Wang X; Xu T; Xie W
Autophagy; 2019 Jul; 15(7):1258-1279. PubMed ID: 30786811
[TBL] [Abstract][Full Text] [Related]
14. Impact of MET inhibition on small-cell lung cancer cells showing aberrant activation of the hepatocyte growth factor/MET pathway.
Taniguchi H; Yamada T; Takeuchi S; Arai S; Fukuda K; Sakamoto S; Kawada M; Yamaguchi H; Mukae H; Yano S
Cancer Sci; 2017 Jul; 108(7):1378-1385. PubMed ID: 28474864
[TBL] [Abstract][Full Text] [Related]
15. Involvement of PI3K/Akt signaling pathway in hepatocyte growth factor-induced migration of uveal melanoma cells.
Ye M; Hu D; Tu L; Zhou X; Lu F; Wen B; Wu W; Lin Y; Zhou Z; Qu J
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):497-504. PubMed ID: 18234991
[TBL] [Abstract][Full Text] [Related]
16. Hepatocyte growth factor enhances death receptor-induced apoptosis by up-regulating DR5.
Li Y; Fan X; Goodwin CR; Laterra J; Xia S
BMC Cancer; 2008 Nov; 8():325. PubMed ID: 18992144
[TBL] [Abstract][Full Text] [Related]
17. Met and hepatocyte growth factor/scatter factor signal transduction in normal melanocytes and melanoma cells.
Halaban R; Rubin JS; Funasaka Y; Cobb M; Boulton T; Faletto D; Rosen E; Chan A; Yoko K; White W
Oncogene; 1992 Nov; 7(11):2195-206. PubMed ID: 1331934
[TBL] [Abstract][Full Text] [Related]
18. HGF/MET Signaling in Malignant Brain Tumors.
Mulcahy EQX; Colόn RR; Abounader R
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33066121
[TBL] [Abstract][Full Text] [Related]
19. Co-overexpression of Met and hepatocyte growth factor promotes systemic metastasis in NCI-H460 non-small cell lung carcinoma cells.
Navab R; Liu J; Seiden-Long I; Shih W; Li M; Bandarchi B; Chen Y; Lau D; Zu YF; Cescon D; Zhu CQ; Organ S; Ibrahimov E; Ohanessian D; Tsao MS
Neoplasia; 2009 Dec; 11(12):1292-300. PubMed ID: 20019837
[TBL] [Abstract][Full Text] [Related]
20. Expression array analysis of the hepatocyte growth factor invasive program.
Cecchi F; Lih CJ; Lee YH; Walsh W; Rabe DC; Williams PM; Bottaro DP
Clin Exp Metastasis; 2015 Oct; 32(7):659-76. PubMed ID: 26231668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
